-
TIL Therapy Amplifies the Immune System’s Attack on Melanoma
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Consider Immunotherapy Before Surgery for Melanoma
Immunotherapy before surgery is proving to be an effective treatment against melanoma.
by Sandra Gordon
-
A Treatment That Came Just in Time
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
Expanding Immunotherapy
At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.
by Kevin McLaughlin
-
How Long Do Immunotherapy Side Effects Last?
For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.
by Anna Goshua
-
Immunotherapy Indications Withdrawn
In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
-
Patient Advocates Tune in for Precision Medicine Primer
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast Cancer
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Cancer Talk
Navigating Out of Financial Toxicity
People with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona
Taking Answers HomeAdvocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
Lifestyle Choices and CancerWhat people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin
Improving Colorectal Cancer Screening OptionsTests currently in development seek to offer greater accuracy and reach more people.
by Eric Fitzsimmons